Arcus Biosciences Inc’s filing revealed that its Chief Operating Officer Jarrett Jennifer unloaded Company’s shares for reported $0.2 million on Mar 27 ’24. In the deal valued at $17.55 per share,11,551 shares were sold. As a result of this transaction, Jarrett Jennifer now holds 215,253 shares worth roughly $3.38 million.
Then, Jarrett Jennifer sold 13,449 shares, generating $240,941 in total proceeds. Upon selling the shares at $17.92, the Chief Operating Officer now owns 226,804 shares.
Before that, Jarrett Jennifer sold 34,070 shares. Arcus Biosciences Inc shares valued at $685,148 were divested by the Chief Operating Officer at a price of $20.11 per share. As a result of the transaction, Jarrett Jennifer now holds 240,253 shares, worth roughly $3.77 million.
BofA Securities initiated its Arcus Biosciences Inc [RCUS] rating to a Neutral in a research note published on November 18, 2022; the price target was $33. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in mid October with a ‘”an Overweight”‘ rating. Berenberg started covering the stock on November 24, 2020. It rated RCUS as “a Buy”.
Price Performance Review of RCUS
On Friday, Arcus Biosciences Inc [NYSE:RCUS] saw its stock jump 1.29% to $15.70. Over the last five days, the stock has gained 0.96%. Arcus Biosciences Inc shares have fallen nearly -17.80% since the year began. Nevertheless, the stocks have fallen -15.41% over the past one year. While a 52-week high of $25.47 was reached on 02/27/24, a 52-week low of $12.95 was recorded on 04/19/24. SMA at 50 days reached $17.26, while 200 days put it at $17.37. A total of 0.54 million shares were traded, compared to the trading of 0.46 million shares in the previous session.
Levels Of Support And Resistance For RCUS Stock
The 24-hour chart illustrates a support level at 15.34, which if violated will result in even more drops to 14.98. On the upside, there is a resistance level at 16.21. A further resistance level may holdings at 16.72. The Relative Strength Index (RSI) on the 14-day chart is 46.57, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.31, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 36.51%. Stochastics %K at 53.12% indicates the stock is a holding.
The most recent change occurred on November 23, 2020 when Evercore ISI began covering the stock and recommended ‘”an Outperform”‘ rating .
